Application no. and date | 11851933.9 (espacenet) (Federated) (European Patent Register), 20111221 | Patent/reg. no. and date | DK/EP 2654781, 20180124 | Publication date | 20131030 | Priority no. and date | US 974739, 20101221, US 97473910, 20101221, US 201013974739, 20101221, US 201161529682 P, 20110831 | EP pub. no. and date |
EP 2654781 20131030 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH, Oklahoma Medical Research Foundation, 825 N.E. 13th Street
Oklahoma City, OK 73104, US | Applicant ref. no. | SH/GP/156829 | Inventor | MCEVER, Rodger, P., 1716 Guilford Lane
Oklahoma City, OK 73120, US, ROLLINS, Scott, 5501 White Fences
Oklahoma City, OK 73131, US, ROTHER, Russell, 10325 Forest Meadow Drive
Oklahoma City, OK 73151, US, ALVAREZ, Richard, 4817 Clipper Xing
Edmond, OK 73013-9007, US, KAWAR, Ziad, S., 333 N W. 5th Street, Apt. 1802
Oklahoma City, OK 73120, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61P 37/00 (2006.01) , A61P 7/02 (2006.01) , A61P 7/06 (2006.01) , C07K 16/28 (2006.01) | Title | Anti-P-selectin-antistoffer og fremgangsmåder til disses anvendelse og identifikation | Int. application no. | US2011066470 | Int. publication no. | WO2012088265 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|